congresses and meetings

ICD lead session at Heart Rhythm meeting, as reported by cardiac electrophysiologist John Mandrola, sounds like it gave the subject a thorough going-over and concluded that St.Jude’s Durata appears to significantly outperform its predecessor, while not yet having a big enough body of data behind it to convince the naysayers.

Andrew technologies claims its solution to lipoplasty avoids the need for traumatic cutting of fat, using as it does its clever liquefaction technology to selectively target fat cells.

The International Medical Device Industry Compliance Conference on 9-11 May at Stockholm’s Sheraton Hotel, and European medtech industry body Eucomed has helpfully drawn the attention of industry to the event with its own succinct assessment.

Stereotactic Radiosurgery techniques are at the forefront of events at this week’s AANS meeting. Varian Medical Systems Inc is demonstrating its wares in what is becoming the gold standard treatment option in specific brain and spinal tumors.

Elsevier Business Intelligence is holding its IN³ Medical Device 360° INvestment and Partnering event in London on April 25 and 26 at the Millennium Gloucester Hotel & Conference Centre.

The Society for Cardiothoracic Surgery in Great Britain and Ireland welcomes Cardiothoracic Anaesthetists Society (ACTA) to join its annual meeting and Cardiothoracic forum in Manchester later this month.

Heavy hitters attending Europe’s premier Trauma, Knee surgery and Arthroscopy congress next month.

Heart Rhythm 2012 is looking into view. Wonder if they’ll mention ICD leads.

Crux’s Vena Cava Filter is looking like a winner with good investigator feedback and clinical results as reported at last week’s Society of Interventional Radiology meeting in San Francisco.

View from the Med: Week 13 is a good read… as ever.

Vasostitch looks like a clever device for accessing and then closing tissue during femoral or transapical insertion of therapeutic devices. The company pitched up at this year’s ACC, so we look forward to hearing their feedback after the event.

OrbusNeich has issued a news release about a clinical study which supports the company’s claim that its clever “pro-healing” stent technology results in a stent which can be indicated in STEMI patients.

Stent company Stentys reckons its self-expanding product addresses a problem raised in acute myocardial application of existing designs.

ACC sees presentation of data from study in severe aortic stenosis patients treated with Edwards Sapien TAVR option. Results are reassuringly equivalent to open heart surgery, suggesting this may be an additional option in patients not suitable for major surgery.

A study, presented at the ACC meeting in Chicago, shows that low BMI patients are at higher risk of complications during or shortly after ICD implantation.

Medtronic announces strong clinical outcomes for its Corevalve product at ACC meeting.